|
US4021387A
(en)
|
1975-11-19 |
1977-05-03 |
President And Fellows Of Harvard College |
Eosinophilotactic tetrapeptides
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
IT1190891B
(it)
|
1982-06-24 |
1988-02-24 |
Anic Spa |
Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
|
|
US4816449A
(en)
|
1984-08-09 |
1989-03-28 |
Immunetech Pharmaceuticals |
Immunotherapeutic anti-inflammatory peptide agents
|
|
US4613676A
(en)
|
1983-11-23 |
1986-09-23 |
Ciba-Geigy Corporation |
Substituted 5-amino-4-hydroxyvaleryl derivatives
|
|
ZA846192B
(en)
|
1984-08-09 |
1986-03-26 |
Merck Patent Gmbh |
Immunotherapeutic polypeptide agents
|
|
US5728680A
(en)
|
1987-12-30 |
1998-03-17 |
Cytoven J.V. |
Methods for normalizing numbers of lymphocytes
|
|
DK53291D0
(da)
|
1991-03-25 |
1991-03-25 |
Carlbiotech Ltd As |
Smaa peptider og peptidrelaterede stoffer samt farmaceutiske praeparater indeholdende saadanne forbindelser
|
|
US6629646B1
(en)
|
1991-04-24 |
2003-10-07 |
Aerogen, Inc. |
Droplet ejector with oscillating tapered aperture
|
|
US6540154B1
(en)
|
1991-04-24 |
2003-04-01 |
Aerogen, Inc. |
Systems and methods for controlling fluid feed to an aerosol generator
|
|
US5938117A
(en)
|
1991-04-24 |
1999-08-17 |
Aerogen, Inc. |
Methods and apparatus for dispensing liquids as an atomized spray
|
|
US5277175A
(en)
|
1991-07-12 |
1994-01-11 |
Riggs John H |
Continuous flow nebulizer apparatus and method, having means maintaining a constant-level reservoir
|
|
GB9120005D0
(en)
|
1991-09-19 |
1991-11-06 |
Wellcome Found |
Method of administering phospholipid dispersions
|
|
US5355872B1
(en)
|
1992-03-04 |
1998-10-20 |
John H Riggs |
Low flow rate nebulizer apparatus and method of nebulization
|
|
US5284133A
(en)
|
1992-07-23 |
1994-02-08 |
Armstrong Pharmaceuticals, Inc. |
Inhalation device with a dose-timer, an actuator mechanism, and patient compliance monitoring means
|
|
US5329028A
(en)
|
1992-08-05 |
1994-07-12 |
Genentech, Inc. |
Carbohydrate-directed cross-linking reagents
|
|
CN1091138A
(zh)
|
1992-08-27 |
1994-08-24 |
迪金研究有限公司 |
疫苗
|
|
US5358934A
(en)
|
1992-12-11 |
1994-10-25 |
The United States Of America As Represented By The Secretary Of Agriculture |
Materials and methods for control of pests
|
|
US5559209A
(en)
|
1993-02-18 |
1996-09-24 |
The General Hospital Corporation |
Regulator regions of G proteins
|
|
US5497763A
(en)
|
1993-05-21 |
1996-03-12 |
Aradigm Corporation |
Disposable package for intrapulmonary delivery of aerosolized formulations
|
|
WO1997009085A1
(en)
|
1995-09-06 |
1997-03-13 |
Ryder Steven L |
Variable oxygen concentration high-flow nebulizer
|
|
US5823179A
(en)
|
1996-02-13 |
1998-10-20 |
1263152 Ontario Inc. |
Nebulizer apparatus and method
|
|
ES2140998B1
(es)
|
1996-05-13 |
2000-10-16 |
Univ Sevilla |
Procedimiento de atomizacion de liquidos.
|
|
US6126939A
(en)
|
1996-09-03 |
2000-10-03 |
Yeda Research And Development Co. Ltd. |
Anti-inflammatory dipeptide and pharmaceutical composition thereof
|
|
US6017735A
(en)
|
1997-01-23 |
2000-01-25 |
Marie Curie Cancer Care |
Materials and methods for intracellular transport and their uses
|
|
US20030113271A1
(en)
|
1997-01-29 |
2003-06-19 |
University Technology Corporation |
Formulations for pulmonary delivery
|
|
IT1291122B1
(it)
|
1997-03-28 |
1998-12-29 |
Sar Spa |
Micropompa per la nebulizzazione di fluidi con valvola dosatrice perfezionata
|
|
US6096707A
(en)
|
1997-07-11 |
2000-08-01 |
Biotie Therapies Ltd. |
Integrin binding peptide and use thereof
|
|
US6044841A
(en)
|
1997-08-29 |
2000-04-04 |
1263152 Ontario Inc. |
Breath actuated nebulizer with valve assembly having a relief piston
|
|
US6041776A
(en)
|
1998-05-14 |
2000-03-28 |
Briggs, Iii; Stephen W. |
Medical nebulization device
|
|
US6354516B1
(en)
|
1999-11-02 |
2002-03-12 |
Aradigm Corporation |
Pore structures for reduced pressure aerosolization
|
|
SE9900369D0
(sv)
|
1999-02-04 |
1999-02-04 |
Siemens Elema Ab |
Ultrasonic nebuliser
|
|
US6328030B1
(en)
|
1999-03-12 |
2001-12-11 |
Daniel E. Kidwell |
Nebulizer for ventilation system
|
|
EP1076091A1
(en)
|
1999-08-09 |
2001-02-14 |
Universite Catholique De Louvain |
Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds
|
|
AU2001280917A1
(en)
|
2000-08-02 |
2002-02-13 |
Research Development Foundation |
Jet nebulizer assembly for home administration of drugs in aerosols
|
|
US20020077283A1
(en)
|
2000-09-08 |
2002-06-20 |
Sessa William C. |
Caveolin peptides and their use as therapeutics
|
|
US6732944B2
(en)
|
2001-05-02 |
2004-05-11 |
Aerogen, Inc. |
Base isolated nebulizing device and methods
|
|
GB0119852D0
(en)
|
2001-08-15 |
2001-10-10 |
Univ York |
Baculovirus
|
|
MXPA04006629A
(es)
|
2002-01-07 |
2004-11-10 |
Aerogen Inc |
Aparatos y metodos para nebulizar fluidos para inhalacion.
|
|
ES2603067T3
(es)
|
2002-01-15 |
2017-02-23 |
Novartis Ag |
Métodos y sistemas para hacer funcionar un generador de aerosol
|
|
WO2003086278A2
(en)
|
2002-04-05 |
2003-10-23 |
Board Of Regents, The University Of Texas System |
Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions
|
|
JP2005530765A
(ja)
|
2002-05-07 |
2005-10-13 |
ネクター セラピューティクス |
乾燥粉末吸入器のためのカプセル及びそれを製造及び使用する方法
|
|
US20040175384A1
(en)
|
2003-12-12 |
2004-09-09 |
Mohapatra Shyam S. |
Protein kinase C as a target for the treatment of respiratory syncytial virus
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
US20070207158A1
(en)
|
2003-06-17 |
2007-09-06 |
Harrison Roger G |
Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
US7625865B2
(en)
|
2004-03-26 |
2009-12-01 |
Universita Degli Studi Di Parma |
Insulin highly respirable microparticles
|
|
CA2568428C
(en)
|
2004-05-25 |
2020-12-29 |
Attenuon, Llc |
Ligands binding the complex of urokinase-type plasminogen activator (upa) and its receptor (upar) that inhibit downstream upar interactions: identification and use in diagnosis or therapy
|
|
ES2514470T3
(es)
|
2005-05-25 |
2014-10-28 |
Aerogen, Inc. |
Sistemas y métodos de vibración
|
|
TWI299993B
(en)
|
2005-12-15 |
2008-08-21 |
Dev Center Biotechnology |
Aqueous inhalation pharmaceutical composition
|
|
US8058227B2
(en)
|
2006-10-03 |
2011-11-15 |
Medical University Of South Carolina |
Method of treating fibrosis in a subject in need thereof comprising administering a composition comprising a CSD
|
|
EP2074142A4
(en)
|
2006-10-19 |
2010-10-27 |
Angiochem Inc |
COMPOUNDS FOR STIMULATING THE FUNCTION OF P-GLYCOPROTEIN AND APPLICATIONS THEREOF
|
|
US20090068258A1
(en)
|
2007-08-28 |
2009-03-12 |
Lisanti Michael P |
Caveolin-mimetic peptide for prevention and treatment of pulmonary hypertension and right ventricular hypertrophy
|
|
TW200938222A
(en)
|
2007-12-13 |
2009-09-16 |
Glaxo Group Ltd |
Compositions for pulmonary delivery
|
|
US8697840B2
(en)
*
|
2008-03-05 |
2014-04-15 |
Board Of Regents, The University Of Texas System |
Peptide inhibition of lung epithelial apoptosis and pulmonary fibrosis
|
|
WO2009152453A2
(en)
|
2008-06-12 |
2009-12-17 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for treating pulmonary hypertension
|
|
AU2009291747B2
(en)
|
2008-09-10 |
2016-05-26 |
Genentech, Inc. |
Methods for inhibiting ocular angiogenesis
|
|
DK2349314T3
(da)
|
2008-10-21 |
2013-05-27 |
Baxter Int |
Lyofiliserede præparater af rekombinant VWF
|
|
GB2466121B
(en)
|
2008-12-15 |
2010-12-08 |
Amira Pharmaceuticals Inc |
Antagonists of lysophosphatidic acid receptors
|
|
SG176053A1
(en)
|
2009-05-15 |
2011-12-29 |
Intermune Inc |
Methods of treating hiv patients with anti-fibrotics
|
|
US20110129444A1
(en)
|
2009-09-28 |
2011-06-02 |
Intermune, Inc |
Novel macrocyclic inhibitors of hepatitis c virus replication
|
|
ES2738114T3
(es)
|
2010-02-11 |
2020-01-20 |
Ablynx Nv |
Métodos y composiciones para la preparación de aerosoles
|
|
EP2635686B1
(en)
*
|
2010-11-05 |
2018-03-28 |
The Regents of The University of California |
Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
|
|
SG11201405830VA
(en)
|
2012-03-27 |
2014-10-30 |
Genentech Inc |
Methods of prognosing, diagnosing and treating idiopathic pulmonary fibrosis
|
|
WO2013184482A1
(en)
|
2012-06-04 |
2013-12-12 |
Yale University |
Method of treating and preventing ocular angiogenesis
|
|
BR112015022831A2
(pt)
|
2013-03-13 |
2017-08-22 |
Forest Laboratories Holdings Ltd |
Composições farmacêuticas micronizadas
|
|
ES2875853T3
(es)
|
2013-03-15 |
2021-11-11 |
Univ Texas |
Método de tratar fibrosis
|
|
CN104274827B
(zh)
|
2013-07-01 |
2020-07-14 |
上海贺普药业股份有限公司 |
贺普拉肽的制剂
|
|
PE20160789A1
(es)
|
2013-11-04 |
2016-08-17 |
Univ Texas |
Composiciones y metodos para admistracion de una enzima a las vias respiratorias de un sujeto
|
|
ES2806027T3
(es)
*
|
2013-11-26 |
2021-02-16 |
Univ Yale |
Nuevas composiciones penetrantes de células y métodos de uso de las mismas
|
|
JP6692751B2
(ja)
|
2013-11-26 |
2020-05-13 |
イーアンドビー テクノロジーズ エルエルシー |
新規カベオリンモジュレーターを使用する自己免疫および／または炎症疾患の治療
|
|
KR102698051B1
(ko)
|
2015-02-27 |
2024-08-26 |
더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 |
폴리펩타이드 치료제 및 이의 용도
|
|
KR101845590B1
(ko)
|
2015-09-25 |
2018-04-05 |
단국대학교 천안캠퍼스 산학협력단 |
유전자를 이용한 폐암 예후예측용 조성물
|
|
CN107216394B
(zh)
*
|
2017-06-21 |
2020-10-09 |
江南大学 |
一种小窝蛋白-1脚手架区融合多肽的制备方法及其应用
|
|
US20190224243A1
(en)
|
2018-01-25 |
2019-07-25 |
Musc Foundation For Research Development |
Enhancement of the Beneficial Effects of Mesenchymal Stem Cell Treatment by the Caveolin-1 Scaffolding Domain Peptide and Subdomains
|
|
WO2020055812A1
(en)
|
2018-09-10 |
2020-03-19 |
Lung Therapeutics, Inc. |
Modified peptide fragments of cav-1 protein and the use thereof in the treatment of fibrosis
|
|
WO2020055824A1
(en)
|
2018-09-10 |
2020-03-19 |
Board of Regents, The University of the Texas System |
Dry powder formulation of caveolin-1 peptides and methods of use thereof
|
|
US20240082342A1
(en)
|
2018-11-21 |
2024-03-14 |
Board Of Regents, The University Of Texas System |
Peptide therapeutics for increasing lung cell viability
|
|
US20220370544A1
(en)
|
2018-11-21 |
2022-11-24 |
Board Of Regents, The University Of Texas System |
Peptide therapeutics for acute and chronic airway and alveolar diseases
|
|
EP3937966B1
(en)
*
|
2019-03-11 |
2026-05-06 |
Rein Therapeutics, Inc. |
Compositions and methods for protecting type 2 alveolar epithelial cells (aec2)
|
|
US12097222B2
(en)
|
2019-06-06 |
2024-09-24 |
Spiritus Therapeutics, Inc. |
Methods for attenuating viral infection and for treating lung injury
|
|
CN111671886B
(zh)
|
2020-03-05 |
2022-11-15 |
上海甘翼生物医药科技有限公司 |
一种预防高危易感人群感染冠状病毒或发生冠状病毒感染疾病的药物组合及其用途
|
|
US20230159608A1
(en)
|
2020-04-21 |
2023-05-25 |
Lung Therapeutics, Inc. |
Modified peptide fragments of cav-1 protein and uses thereof
|
|
WO2021257816A2
(en)
|
2020-06-19 |
2021-12-23 |
Lung Therapeutics, Inc. |
Modified caveolin-1 peptides for the treatment of pathogen-induced lung injury
|
|
CA3209638A1
(en)
|
2021-02-25 |
2022-09-01 |
Lung Therapeutics, Inc. |
Biomarkers for the treatment of interstitial lung disease
|
|
US12449810B2
(en)
|
2021-03-01 |
2025-10-21 |
The Boeing Company |
Autonomous maneuver generation to mate connectors
|
|
US20250041383A1
(en)
|
2021-06-17 |
2025-02-06 |
Lung Therapeutics, Inc. |
Modified caveolin-1 peptides for the treatment of post-acute covid-19
|
|
EP4419129A4
(en)
|
2021-10-22 |
2025-09-24 |
Rein Therapeutics Inc |
MODIFIED CAVEOLIN-1 PEPTIDES FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE
|